Cowen and Company’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Cowen and Company’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-21,785	Closed	-$33K	–	576
2019 Q4	$33K	Buy	+21,785	New	+$30.7K	﹤0.01%	342

Other funds holding NFH.WS

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

WCA

Windsor Creek Advisors Bethel, Vermont $331M AUM 13.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Cowen and Company's NFH.WS Position: Q1 2020 in Review

Cowen and Company sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2020, closing a stake of 21,785 shares — an estimated $33K sold.

Cowen and Company first reported a position in NFH.WS in Q4 2019 and held it in 1 quarter. The position peaked at $33K in Q4 2019. 19 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2020.

Cowen and Company reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2020 after selling out during the quarter.
Cowen and Company sold 21,785 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2020, an estimated $33K.
Cowen and Company first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 1 quarter.
Cowen and Company's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $33K in Q4 2019.
19 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2020.

Based on Cowen and Company's 13F filing for Q1 2020, filed 11 May 2020.